The biggest development in weight-loss medicine since bariatric surgery (not to mention less invasive), the medications, which were initially approved to treat type 2 diabetes, have exploded in popularity in recent years
The article lists contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, and pregnancy, and notes neither medication suits everyone
Another clinical trial led by Regeneron is currently evaluating the synergistic effects of trevogrumab and garetosmab in combination with semaglutide in obese patients, with the goal of reducing fat mass while preserving lean mass (NCT06299098)
This helps ensure you are not still spreading norovirus to friends, coworkers, or family members
The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity